PEStore

Buyout PE

Cairngorm Capital Partners

Cairngorm Capital Partners acquires controlling stakes in established, profitable businesses, from Edinburgh, United Kingdom. It states a focus on healthcare & life sciences, business & professional services, real estate and environmental & safety.

Disclosed holdings14
Most recent fund2023filing since 2015
HeadquartersEdinburgh, United Kingdom
Largest single fundNot stated

Stated investment criteria

What Cairngorm Capital Partners says it buys

Read from Cairngorm Capital Partners’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

Maximum enterprise value it states£200m1
Revenue it states£10m to £200m1
EBITDA it states£2m to £20m2
Transaction typesDistressed, Recapitalisation, Growth, Carve-out2

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. Cairngorm Capital Partners states that it takes minority stakes rather than control. Nothing here is a commitment by Cairngorm Capital Partners to consider any particular business, and nothing on this page is represented as being for sale.

SEC filings

What Cairngorm Capital Partners has raised

From this firm's own Form D filings. A fund files one within fifteen days of its first sale, under penalty of perjury, which makes these the hardest numbers on the page.

Vehicles filed4
Total capital raisedNot disclosed in filings
Largest single vehicleNot disclosed in filings
Filing history2015 to 2023
Smallest accepted commitmentNone stated
Filed fromGUERNSEY

Form D covers US-domiciled vehicles raised from accredited investors. It will not capture a fund raised outside the United States, separately managed accounts, or capital deployed off balance sheet, so treat these as a floor rather than a total.

Regulatory record

How Cairngorm Capital Partners is registered

From Companies House, the United Kingdom's statutory company register.

Companies House numberOC390319
Incorporated2014-01-13
Register statusActive
Officers on the register2

Portfolio

Disclosed holdings

Companies Cairngorm Capital Partners lists on its own website. No investment years are published.

CompanyInvestedYears heldRecorded transaction
City Energy
E Zec
EMED Group
IBMG
MJ Wilson
Millbrook Healthcare
Millbrook Healthcare Group
Nationaltimbergroup
Sagehomenow
Sentry Fire Safety Group
Sentrydoors
Verso Wealth Management
Versowmgroup
Whytebikes

Compiled from Cairngorm Capital Partners’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Cairngorm Capital Partners?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other buyout pe investors active in healthcare & life sciences.